The prevalence of gallstones has significantly increased, such that only in the US about one million cases are diagnosed each year (
1). This disease imposes a significant therapeutic-economic burden on the healthcare systems, even in western countries, to the extent that between 10% - 20% of people in the European and American societies are suffering from gallstones (
2,
3) and refer to hospital emergency rooms with acute abdominal pains (
4). In most cases, gallstones symptoms are not significant. As about 25% - 50% of those suffering from gallstone develop several complications, it is necessary to remove their gallbladder (
5) using surgical techniques such as laparoscopic cholecystectomy, which is highly common. Laparoscopic cholecystectomy is one of the most common abdominal surgeries and the standard treatment for gallstones and cholecystitis (
6). In addition, it is a non-invasive technique (
7) intended to reduce the potential damages of the disease (
8). Apart from several advantages, laparoscopic cholecystectomy is associated with better hemostasis compared to open surgeries (
9). Due to several reasons, including the need for a small incision, low pain, short duration of hospitalization, early recovery, early start of eating food, and, in general, the quick return to daily activities, the laparoscopic cholecystectomy is the preferred option to treat most of the cases who suffer from the gallbladder (
10,
11). According to the currently available evidence, about 0.04 of cases who underwent the laparoscopic cholecystectomy develop complications (
12) such as bile duct injury, acute biliary tract obstruction, extrahepatic biliary duct rupture, falling gallstones into the abdominal cavity, and the subsequent formation of an abscess. Moreover, it also may cause some intraoperative complications, such as hemodynamic changes during blowing the gas into the peritoneum, including cardiac output, increased systemic vascular resistance, hypertension, heart rate changes, and reduced respiratory capacity (
13). In addition, it may cause some changes in the body, such as changes in acid-base, pulmonary status, cardiovascular system, and hemodynamic. There are reported that attributed changes in the liver function to impaired portal vein flow, decreased venous flow, and variations in intracranial pressure (
14). A dysfunction in the blood flow to the liver not only may result in liver dysfunction but also can disrupt the production of proteins made in hepatocytes, including coagulation factors (PT, PTT, and INR) (
15). Some empirical evidence reported PT and PTT levels following laparoscopic cholecystectomy (
15,
16); however, the evidence are still inconclusive over changes in the INR factor (
16).